September 24, 2014 The Honorable Jim Greenwood discusses the art and science of multi-stakeholder collaborations The Honorable Jim Greenwood, President and CEO of Biotechnology Industry Organization (BIO) and C-Path Board member, participated
September 22, 2014 Critical Path Institute Receives Second Grant for Advancing Tuberculosis Treatments
September 14, 2014 The Patient-Reported Outcome (PRO) Consortium Lessons Learned Along the Path to PRO Instrument Qualification
July 5, 2014 PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force
June 23, 2014 Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research, on FDA’s Critical Path Initiative